XTransfer
  • Products & Services
  • About Us
  • Help & Support
English
Create account

Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug

HS Code: 3002150090

SECTION 6

PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES

CHAPTER 30

Pharmaceutical products

HEADING 3002

 Human blood; animal blood prepared for therapeutic

HS Code Structure Breakdown

LevelCodeDescription
Section6PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
Chapter30Pharmaceutical products
Heading3002 Human blood; animal blood prepared for therapeutic
Subheading300215Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug
Commodity3002150090Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug
Advertisement banner

Pay and get paid in local currency. Save up to 80% on your currency exchanges.

Get it for free now

HS Code 3002150090 for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug

Product Wiki

Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.

Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug, with its export volume maintaining a high level over the long term.

Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug.

With technological advancements and the diversification of market demands, the scope of application for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug continues to expand, driving the development of related industries.

Currently, the global supply-demand balance of Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.

Partner

OCBC
DBS
BANK OF CHINA

Our licenses

China

China

HK MSO License

HK MSO License

Singapore

Singapore

UK API License

UK API License

Netherlands

Netherlands

US MSB

US MSB

CA MSB

CA MSB

AU RSP

AU RSP

HS Code FAQ

What is the HS code for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug? Which HS classification does it belong to?

The HS code for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug is 3002150090. This product is classified under: Section 6, Chapter 30 (if applicable, otherwise not shown), Heading 3002 (if applicable, otherwise not shown). This code is used in international trade for the standardized classification and customs declaration of Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug.

What are the import VAT rate and export tax rebate rate for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug?

The import VAT rate and export tax rebate rate for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug depend on its specific HS Code, product category, and the latest customs tariff policies. In general, import VAT rates may fall under different brackets such as 13% or 9%, while export tax rebate rates may vary between 0%, 9%, and 13%. Different products are subject to different tax regulations and rebate policies. Please refer to the latest information released by customs and tax authorities for the most accurate rates.

Is the HS code for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug the same across different countries?

The HS code for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug under the internationally standardized HS coding system is 3002150090, but some countries may use different suffix extensions. It is recommended to confirm based on the customs regulations of the destination country.

How can I confirm whether Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug corresponds to the correct HS code?

You can determine this by checking the function, material, and usage of Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug, and verifying whether the corresponding HS code matches the actual classification rules. If necessary, official classification guidelines or historical declaration cases can also be referenced for validation.

How are the taxes and duties for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug calculated?

The taxes and duties for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug usually consist of customs duties, value-added tax , and other additional charges. The exact amount depends on the declared value and the import policies of the destination country.

What happens if the HS code 3002150090 for Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug is declared as a different HS code?

If Other immunological products, which have been dosed or made into retail packaging for the purpose of splitting the anti-cancer drug (HS Code: 3002150090) is declared incorrectly, it may result in customs clearance delays, tax adjustments, or compliance risks. It is recommended to correct the declaration as soon as possible or contact the customs clearance service provider for assistance. Platforms such as XTransfer can also provide declaration and risk control support to help reduce risks.